🔎 Trials Near Me

Início › Colite ulcerativa › Califórnia

Ensaios clínicos de Colite ulcerativa em Califórnia

40 estudos para Colite ulcerativa estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Clinnova Research /ID# 280509, Anaheim
  • Southern California Res. Ctr /ID# 280476, Coronado
  • Gastro Care Institute /ID# 281071, Lancaster
  • e mais 2
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology and Liver Institute, Escondido
  • United Clinical Research Institute, Murrieta
RecrutandoFase 4
Idades de 18 a 80 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • Rady Children's Hospital /ID# 271873, San Diego
  • University of California San Francisco - Mission Bay /ID# 273022, San Francisco
RecrutandoFase 3
Idades de 2 a 17 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07071519

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
  • Southern California GI and Liver Centers (SCLC), Coronado
  • Valley View Research, Garden Grove
  • e mais 6
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Palo Alto
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 024, Canoga Park
  • Site 023, La Jolla
  • Site 012, Lancaster
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-018, San Diego
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Clinnova Research ( Site 1042), Anaheim
  • Southern California Research Center ( Site 1044), Coronado
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Gastro Care Institute, Lancaster
  • Medical Associates Research Group, Inc., San Diego
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Southern California Research Center, Coronado
  • Om Research LLC, Lancaster
  • e mais 7
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Loma Linda University Health System, Loma Linda
  • Cedars-Sinai Medical Center, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
  • e mais 1
RecrutandoFase 2/3
Idades de 2 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • e mais 1
RecrutandoFase 3
Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT03816345

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • UCSF Medical Center at Mission Bay, San Francisco
RecrutandoFase 3
Idades de 2 a 19 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04844606

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Clinnova Research - Anaheim, Anaheim
  • Om Research LLC, Lancaster
  • Biopharma Informatic, LLC, Los Angeles
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • GMC Clinical Research, Folsom
  • Om Research LLC, Temple City
  • e mais 1
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • Cedars-Sinai Medical Center, Los Angeles
  • Hoag Hospital Newport Beach, Newport Beach
RecrutandoFase 4
Idades de 18 a 65 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • United Medical Doctors CA - Site Number: 8400044, Murrieta
  • Om Research, LLC - Victorville - Site Number: 8400022, Victorville
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Clinnova Research, Anaheim
  • Gastro SB Clinic, Chula Vista
  • United Medical Doctors, Los Alamitos
  • e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
  • Alliance Research Institute - Site Number: 8400008, Canoga Park
  • Southern California GI & Liver Centers - Site Number: 8400062, Coronado
  • e mais 13
RecrutandoFase 3
Idades de 16 a 80 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07184996

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

  • Vanda Investigational Site, Chula Vista
RecrutandoFase 3
Idades de 18 a 75 · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07686081

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

  • Cedars Sinai Medical Center, Los Angeles
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07034443

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Hoag Hospital, Irvine
  • UC San Diego Health, La Jolla
  • Cedars-Sinai, Los Angeles
  • e mais 1
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Gastroenterology Medical Clinic (Objective Health), Folsom
  • Center for Colorectal Innovation, Los Angeles
  • Hoag Hospital, Newport Beach
  • e mais 1
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06571669

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Children's Hospital Of Orange County, Orange
RecrutandoFase 3
Idades de 2 a 17 · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06100289

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Scripps Clinic Torrey Pines, La Jolla
  • United Medical Doctors, Los Alamitos
  • United Medical Doctors, Los Alamitos
RecrutandoEstudo observacional
Idades de 18 a 64 · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Valley View Wellness Medical Center, Garden Grove
  • Loma Linda Children's Hospital, Loma Linda
  • Loma Linda University Clinical Trial Center, Loma Linda
  • e mais 7
RecrutandoFase 2
Idades de 12 a 17 · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Loma Linda University, Loma Linda
  • Children's Hospital of Orange County, Orange
  • Stanford Children's Health, Palo Alto
RecrutandoFase 3
Idades de 2 a 17 · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT06405087

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

  • Amicis Research Center, Valencia
RecrutandoFase 1
Idades de 18 a 65 · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT05666960

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

  • Children's Hospital Los Angeles, Los Angeles
RecrutandoFase 2
Idades de 7 a 21 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT05218850

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Rady Children's Hospital - San Diego - PIN, San Diego
RecrutandoFase 3
Idades 2 e acima · Todos os sexos · Atualizado em 7 de mai. de 2026 · NCT05442567

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

  • Investigational Site Number: 8400009, Escondido
  • Investigational Site Number: 8400006, Lancaster
  • Investigational Site Number: 8400025, Thousand Oaks
RecrutandoFase 2
Idades de 18 a 75 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT06975722

Fermented Food-Supplemented Diet in Ulcerative Colitis

  • Stanford University, Palo Alto
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT04401605

The Influence of a Fasting Mimicking Diet on Ulcerative Colitis

  • Stanford University, Palo Alto
Recrutando
Idades de 18 a 70 · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT03615690

Impact of Prebiotics in Ulcerative Colitis

  • UCLA, Los Angeles
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT06495658

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • University of Los Angeles Health, Los Angeles
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 8 de jan. de 2026 · NCT05987852

Effects of Pomegranate Juice on Ulcerative Colitis

  • West Los Angeles VA Medical Center, Los Angeles
  • UCLA Center for Human Nutrition, Los Angeles
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 9 de dez. de 2025 · NCT07115862

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

  • Bausch Health Site 008, Garden Grove
RecrutandoFase 4
Idades de 5 a 17 · Todos os sexos · Atualizado em 16 de set. de 2025 · NCT04314375

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

  • University of California San Diego, La Jolla
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 16 de mai. de 2023 · NCT04721873

Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.